102 results
8-K
EX-99.1
FGEN
FibroGen Inc
26 Feb 24
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
4:08pm
on the National Reimbursement Drug List.
For 2024, we anticipate FibroGen’s full year net product revenue under U.S. GAAP to range between $120 million to $135
S-3ASR
n1eqjbrk5ho hpsni3
8 Aug 22
Automatic shelf registration
5:12pm
8-K
EX-99.1
7jnw0e1
8 Aug 22
FibroGen Reports Second Quarter 2022 Financial Results
4:07pm
8-K
EX-99.1
bezrnvq0z0yni
9 May 22
FibroGen Reports First Quarter 2022 Financial Results
4:09pm